In 2023, China stood at a baseline metric for the number of scientific publications among the world’s top 10% cited in infectious diseases. Forecasted data from 2024 to 2028 reveals a steady year-on-year increase. Specifically, from 2024 onwards, China is projected to see a gradual uptick, with year-on-year growth estimating to hover around 10.04% annually. This reflects a consistent trend of growing influence in the field, with a Compound Annual Growth Rate (CAGR) reflecting a robust annual increase over this five-year period.
Future trends to watch for include China's strategic emphasis on R&D investments, international collaborations, and policy enhancements, potentially accelerating their global impact in infectious disease research even further beyond 2028.
